Skip to main content

Joint Canada-Israel Health Research Program – Phase II

March 9, 2022

Given the scientific impact of phase I of the Joint Canada-Israel Health Research Program (JCIHRP) and the funding partners’ strong relationship, shared vision and commitment to the scientific community, the partner organizations approved the launch of phase II of JCIHRP for a second cycle of funding. 

Phase II of JCIHRP will invest in cutting-edge biomedical and global health research. The program will support world-class research teams co-led by three principal investigators — one each from Canada, Israel and a low- and middle-income country (LMIC). The teams will integrate researchers from all three geographic areas with the intention of strengthening scientific capacity, promoting collaboration, equitable partnerships and scientific excellence. 

This first competitive call under phase II is directed toward proposals at the intersection between non-communicable chronic disease and infectious diseases while strengthening capacity in Canada, Israel and LMICs.  

With the second phase of JCIHRP, the presidents of the partner agencies renew their collective commitment to support high-quality research and international collaboration among Canada, Israel and LMICs:

The Israel Science Foundation is extremely excited about the renewal of this joint program for a variety of reasons. First and foremost, the research achievements of both Israeli and Canadian researchers in different fields are truly outstanding and, in many cases, highly complementary. Second, we are genuinely excited to continue to work with IDRC, CIHR and the Azrieli Foundation, with whom we share the commitment and dedication to scientific excellence. Finally, we look forward to the active and fruitful involvement of researchers and students from developing countries in our ongoing endeavour.”

Professor Daniel Zajfman
Chair, Academic Board, Israel Science Foundation

“Science is an international and collaborative undertaking. With this initiative linking leading researchers from Canada, Israel and low- and middle-income countries, the Azrieli Foundation furthers its commitment to supporting scientific excellence and encouraging multilayered collaborations. Bringing together exceptional, innovative scientists from different countries will accelerate global health research, strengthening our shared goals to advance human health and well-being worldwide. We believe the renewal of this program will lead to biomedical research advances that can truly make a difference—in Canada, in Israel and globally.”

Dr. Naomi Azrieli
Chair and CEO, The Azrieli Foundation

“Phase 2 of the Joint Canada-Israel Health Research Program will build on IDRC’s expertise in global health, our investment in COVID-19-related research and our long history of international scientific collaboration. We are pleased to continue this partnership with the Canadian Institutes of Health Research, Canada’s Azrieli Foundation and the Israel Science Foundation, working on emerging health challenges in a post COVID-19 scientific environment. This will contribute to innovations that will transform lives around the world.”

Dr. Jean Lebel
President, International Development Research Centre

“CIHR is honoured to maintain its support of the Canada-Israel Health Research Program. Our two countries have a long-standing history of collaboration, and this research program provides an opportunity to build on our mutual areas of expertise. The program takes advantage of Canada’s research strengths related to biomedical research, global health and COVID-19 as well as our commitment to research partnerships.”

Dr. Michael J. Strong
President, Canadian Institutes of Health Research

 

Our projects

Explore research projects that we support.